The 2023-2024 Respiratory Virus Season: Embracing the Evolving Landscape
The article provides an overview of the challenges and developments expected for the 2023-2024 respiratory virus season. It discusses the ongoing influence of COVID-19 alongside other respiratory viruses like influenza and RSV. The piece highlights advancements in diagnostic tests and public health strategies aimed at managing the evolving landscape of respiratory illnesses.
Embracing Ethical Innovation: Breaking New Ground with Animal-Free Immunoassay Blockers
Embracing Ethical Innovation: Breaking New Ground with Animal-Free Immunoassay Blockers” discusses the shift towards more ethical laboratory practices by adopting animal-free immunoassay blockers. It explores how this innovation not only aligns with ethical standards but also enhances assay performance and reproducibility, supporting a sustainable and responsible scientific future.
Meridian Bioscience Senior Director of R&D, Dr. Dan (Dror) Siman-Tov, to Spotlight Lateral Flow Innovations at the Advanced Lateral Flow Conference 2024
CINCINNATI, OHIO, February 12, 2024 (PRNewswire) – Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, is proud to announce that Dr. Dan (Dror) Siman-Tov, Ph.D., MBA, Senior Director of R&D, Diagnostics, will be presenting at the Advanced Lateral Flow Conference 2024. The event is scheduled to take […]
Unlocking Success: Top Criteria to Consider when Choosing the Best Reagents for High-Throughput Assays
The article provides a comprehensive guide on selecting reagents for high-throughput assays, emphasizing the importance of enzyme sensitivity and specificity, compatibility with automated systems, and the advantages of using glycerol-free reagents. It highlights how these factors contribute to the accuracy and efficiency of diagnostics.